898 related articles for article (PubMed ID: 16741184)
1. Inflammation and atherosclerosis: novel insights into plaque formation and destabilization.
Stoll G; Bendszus M
Stroke; 2006 Jul; 37(7):1923-32. PubMed ID: 16741184
[TBL] [Abstract][Full Text] [Related]
2. Deletion of the angiotensin II type 1a receptor prevents atherosclerotic plaque rupture in apolipoprotein E-/- mice.
Aono J; Suzuki J; Iwai M; Horiuchi M; Nagai T; Nishimura K; Inoue K; Ogimoto A; Okayama H; Higaki J
Arterioscler Thromb Vasc Biol; 2012 Jun; 32(6):1453-9. PubMed ID: 22460554
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological activation of the melanocortin system limits plaque inflammation and ameliorates vascular dysfunction in atherosclerotic mice.
Rinne P; Silvola JM; Hellberg S; Ståhle M; Liljenbäck H; Salomäki H; Koskinen E; Nuutinen S; Saukko P; Knuuti J; Saraste A; Roivainen A; Savontaus E
Arterioscler Thromb Vasc Biol; 2014 Jul; 34(7):1346-54. PubMed ID: 24790139
[TBL] [Abstract][Full Text] [Related]
4. Role of endothelial cell-derived angptl2 in vascular inflammation leading to endothelial dysfunction and atherosclerosis progression.
Horio E; Kadomatsu T; Miyata K; Arai Y; Hosokawa K; Doi Y; Ninomiya T; Horiguchi H; Endo M; Tabata M; Tazume H; Tian Z; Takahashi O; Terada K; Takeya M; Hao H; Hirose N; Minami T; Suda T; Kiyohara Y; Ogawa H; Kaikita K; Oike Y
Arterioscler Thromb Vasc Biol; 2014 Apr; 34(4):790-800. PubMed ID: 24526691
[TBL] [Abstract][Full Text] [Related]
5. Hypoxia-Inducible Factor Prolyl 4-Hydroxylase-2 Inhibition Protects Against Development of Atherosclerosis.
Rahtu-Korpela L; Määttä J; Dimova EY; Hörkkö S; Gylling H; Walkinshaw G; Hakkola J; Kivirikko KI; Myllyharju J; Serpi R; Koivunen P
Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):608-17. PubMed ID: 26848160
[TBL] [Abstract][Full Text] [Related]
6. CD137 (4-1BB) deficiency reduces atherosclerosis in hyperlipidemic mice.
Jeon HJ; Choi JH; Jung IH; Park JG; Lee MR; Lee MN; Kim B; Yoo JY; Jeong SJ; Kim DY; Park JE; Park HY; Kwack K; Choi BK; Kwon BS; Oh GT
Circulation; 2010 Mar; 121(9):1124-33. PubMed ID: 20176988
[TBL] [Abstract][Full Text] [Related]
7. Nicotinamide phosphoribosyltransferase inhibition reduces intraplaque CXCL1 production and associated neutrophil infiltration in atherosclerotic mice.
Nencioni A; da Silva RF; Fraga-Silva RA; Steffens S; Fabre M; Bauer I; Caffa I; Magnone M; Sociali G; Quercioli A; Pelli G; Lenglet S; Galan K; Burger F; Vázquez Calvo S; Bertolotto M; Bruzzone S; Ballestrero A; Patrone F; Dallegri F; Santos RA; Stergiopulos N; Mach F; Vuilleumier N; Montecucco F
Thromb Haemost; 2014 Feb; 111(2):308-22. PubMed ID: 24196571
[TBL] [Abstract][Full Text] [Related]
8. Statin treatment is not associated with consistent alterations in inflammatory status of carotid atherosclerotic plaques: a retrospective study in 378 patients undergoing carotid endarterectomy.
Verhoeven BA; Moll FL; Koekkoek JA; van der Wal AC; de Kleijn DP; de Vries JP; Verheijen JH; Velema E; Busser E; Schoneveld A; Virmani R; Pasterkamp G
Stroke; 2006 Aug; 37(8):2054-60. PubMed ID: 16809559
[TBL] [Abstract][Full Text] [Related]
9. The intravenous injection of oxidized LDL- or Apolipoprotein B100--Coupled splenocytes promotes Th1 polarization in wildtype and Apolipoprotein E--Deficient mice.
Steinmetz M; Ponnuswamy P; Laurans L; Esposito B; Tedgui A; Mallat Z
Biochem Biophys Res Commun; 2015 Aug; 464(1):306-11. PubMed ID: 26116775
[TBL] [Abstract][Full Text] [Related]
10. Lesion development and response to immunization reveal a complex role for CD4 in atherosclerosis.
Zhou X; Robertson AK; Rudling M; Parini P; Hansson GK
Circ Res; 2005 Mar; 96(4):427-34. PubMed ID: 15662027
[TBL] [Abstract][Full Text] [Related]
11. Histamine H1 receptor promotes atherosclerotic lesion formation by increasing vascular permeability for low-density lipoproteins.
Rozenberg I; Sluka SH; Rohrer L; Hofmann J; Becher B; Akhmedov A; Soliz J; Mocharla P; Borén J; Johansen P; Steffel J; Watanabe T; Lüscher TF; Tanner FC
Arterioscler Thromb Vasc Biol; 2010 May; 30(5):923-30. PubMed ID: 20203300
[TBL] [Abstract][Full Text] [Related]
12. Dietary alpha-lipoic acid supplementation inhibits atherosclerotic lesion development in apolipoprotein E-deficient and apolipoprotein E/low-density lipoprotein receptor-deficient mice.
Zhang WJ; Bird KE; McMillen TS; LeBoeuf RC; Hagen TM; Frei B
Circulation; 2008 Jan; 117(3):421-8. PubMed ID: 18158360
[TBL] [Abstract][Full Text] [Related]
13. Translational Molecular Imaging Tool of Vulnerable Carotid Plaque: Evaluate Effects of Statin Therapy on Plaque Inflammation and American Heart Association-Defined Risk Levels in Cuff-Implanted Apolipoprotein E-Deficient Mice.
Chan JMS; Park SJ; Ng M; Chen WC; Chan WY; Bhakoo K; Chong TT
Transl Stroke Res; 2024 Feb; 15(1):110-126. PubMed ID: 36481841
[TBL] [Abstract][Full Text] [Related]
14. In vivo fluorescence-mediated tomography imaging demonstrates atorvastatin-mediated reduction of lesion macrophages in ApoE-/- mice.
Larmann J; Frenzel T; Schmitz M; Hahnenkamp A; Demmer P; Immenschuh S; Tietge UJ; Bremer C; Theilmeier G
Anesthesiology; 2013 Jul; 119(1):129-41. PubMed ID: 23559030
[TBL] [Abstract][Full Text] [Related]
15. Protective role for Toll-like receptor-9 in the development of atherosclerosis in apolipoprotein E-deficient mice.
Koulis C; Chen YC; Hausding C; Ahrens I; Kyaw TS; Tay C; Allen T; Jandeleit-Dahm K; Sweet MJ; Akira S; Bobik A; Peter K; Agrotis A
Arterioscler Thromb Vasc Biol; 2014 Mar; 34(3):516-25. PubMed ID: 24436372
[TBL] [Abstract][Full Text] [Related]
16. Atheroprotective role of C5ar2 deficiency in apolipoprotein E-deficient mice.
Selle J; Asare Y; Köhncke J; Alampour-Rajabi S; Shagdarsuren G; Klos A; Weber C; Jankowski J; Shagdarsuren E
Thromb Haemost; 2015 Oct; 114(4):848-58. PubMed ID: 26084965
[TBL] [Abstract][Full Text] [Related]
17. Attenuated expression of profilin-1 confers protection from atherosclerosis in the LDL receptor null mouse.
Romeo GR; Moulton KS; Kazlauskas A
Circ Res; 2007 Aug; 101(4):357-67. PubMed ID: 17615372
[TBL] [Abstract][Full Text] [Related]
18. Anti-inflammatory immune skewing is atheroprotective: Apoe−/−FcγRIIb−/− mice develop fibrous carotid plaques.
Harmon EY; Fronhofer V; Keller RS; Feustel PJ; Zhu X; Xu H; Avram D; Jones DM; Nagarajan S; Lennartz MR
J Am Heart Assoc; 2014 Dec; 3(6):e001232. PubMed ID: 25516435
[TBL] [Abstract][Full Text] [Related]
19. Discoidin domain receptor 1 (ddr1) deletion decreases atherosclerosis by accelerating matrix accumulation and reducing inflammation in low-density lipoprotein receptor-deficient mice.
Franco C; Hou G; Ahmad PJ; Fu EY; Koh L; Vogel WF; Bendeck MP
Circ Res; 2008 May; 102(10):1202-11. PubMed ID: 18451340
[TBL] [Abstract][Full Text] [Related]
20. [Role of inflammation in atherogenesis].
Rodríguez G; Mago N; Rosa F
Invest Clin; 2009 Mar; 50(1):109-29. PubMed ID: 19418732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
